
NKT cell activation by local α-galactosylceramide administration decreases susceptibility to HSV-2 infection
Keywords: αGalCer, α-galactosylceramide; CXCL10, C-X-C motif chemokine 10; FCS, fetal calf serum; HSV-1, herpes simplex virus 1; HSV-2, herpes simplex virus 2; IMDM, Iscove's modified Dulbecco's medium; HIV, human immunodeficiency virus; KO, knock out; MEM, Eagle's